Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.41%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$40.2B
AUM Growth
+$172M
(+0.43%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-3.23%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
794
New
108
Increased
186
Reduced
363
Closed
91
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$415M |
| 2 |
RTN
Raytheon Company
RTN
|
$186M |
| 3 |
RTX Corp
RTX
|
$178M |
| 4 |
Marathon Petroleum
MPC
|
$167M |
| 5 |
Deere & Co
DE
|
$146M |
Top Sells
| 1 |
Honeywell
HON
|
$272M |
| 2 |
Walmart
WMT
|
$231M |
| 3 |
Ross Stores
ROST
|
$198M |
| 4 |
DuPont de Nemours
DD
|
$188M |
| 5 |
Owens Corning
OC
|
$144M |
Sector Composition
| 1 | Healthcare | 16.26% |
| 2 | Technology | 15.29% |
| 3 | Financials | 12.82% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Industrials | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVL
551
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $8.39M | 0.02% |
+635,327
| New | +$8.39M |
|
552
Everest Group
EG
$14.3B
| $8.35M | 0.02% |
33,799
-16,600
| -33% | -$4.1M |
|
553
DaVita
DVA
$9.86B
| $8.28M | 0.02% |
147,250
+92,100
| +167% | +$5.18M |
|
|
TPTX
554
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $8.14M | 0.02% |
+200,000
| New | +$8.14M |
|
555
A.O. Smith
AOS
$10.3B
| $8.1M | 0.02% |
+171,720
| New | +$8.1M |
|
556
Liberty Energy
LBRT
$1.7B
| $8.09M | 0.02% |
500,000
| – | – |
|
|
UROV
557
DELISTED
Urovant Sciences Ltd.
UROV
| $7.91M | 0.02% |
1,000,000
-385,000
| -28% | -$3.05M |
|
558
Globe Life
GL
$11.3B
| $7.91M | 0.02% |
+88,400
| New | +$7.91M |
|
559
Halozyme
HALO
$8.76B
| $7.73M | 0.02% |
450,000
+300,000
| +200% | +$5.15M |
|
560
Hanesbrands
HBI
$2.27B
| $7.62M | 0.02% |
442,350
+110
| +0% | +$1.89K |
|
561
Kilroy Realty
KRC
$5.05B
| $7.47M | 0.02% |
101,254
-14,692
| -13% | -$1.08M |
|
562
STMicroelectronics
STM
$24B
| $7.43M | 0.02% |
+421,800
| New | +$7.43M |
|
563
Ironwood Pharmaceuticals
IRWD
$188M
| $7.39M | 0.02% |
675,000
-1,563,750
| -70% | -$17.1M |
|
564
Indaptus Therapeutics
INDP
$3.65M
| $7.38M | 0.02% |
759
| – | – |
|
565
Truist Financial
TFC
$60B
| $7.36M | 0.02% |
+149,800
| New | +$7.36M |
|
|
SILK
566
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $7.29M | 0.02% |
+150,500
| New | +$7.29M |
|
|
FPRX
567
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $7.24M | 0.02% |
1,200,000
+50,000
| +4% | +$302K |
|
568
Fortinet
FTNT
$60.4B
| $7.19M | 0.02% |
468,090
-420,500
| -47% | -$6.46M |
|
569
Arrow Electronics
ARW
$6.57B
| $7.15M | 0.02% |
100,385
-262,384
| -72% | -$18.7M |
|
570
Newell Brands
NWL
$2.68B
| $7.13M | 0.02% |
462,600
-24,400
| -5% | -$376K |
|
571
Northrop Grumman
NOC
$83.2B
| $7.13M | 0.02% |
22,057
-211,134
| -91% | -$68.2M |
|
572
Bread Financial
BFH
$3.09B
| $7.06M | 0.02% |
63,162
-8,382
| -12% | -$937K |
|
573
Aldeyra Therapeutics
ALDX
$334M
| $7.01M | 0.02% |
1,168,822
+50,000
| +4% | +$300K |
|
574
H&R Block
HRB
$6.85B
| $6.97M | 0.02% |
237,800
-12,800
| -5% | -$375K |
|
575
Pentair
PNR
$18.1B
| $6.9M | 0.02% |
+185,597
| New | +$6.9M |
|